Filing excerpt
In the first quarter 2026 Stryker Corporation ("we" or the "Company") announced a change in our organizational structure.
sec.gov/Archives/edgar/data/310764/000031076426000041/syk-20260626.htmRead the full source
Stryker8-K: Restructuring charge
Stryker creates new Ortho Tech business unit via major internal reorganization
What happened
Stryker is combining its orthopaedic instruments portfolio with its Mako and enabling technologies portfolio into a single new business.
Source
Other signals in this filing (1)
- RestructuringStryker restructures, creating new Ortho Tech business by combining two portfolios.Restructuring
Extracted by Autobound
From the Signal API record- Signal
- 8-K: Restructuring charge
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Fiscal year end
- 06/26
- Filed
- Jun 26, 2026
More from Stryker
- PatentsStryker Corporation's patent output is steady: 284 grants in the past year, 19 in the past 30 days.Patents
- RedditWhat next from Trauma?Reddit
- GlassdoorField Service Representative mentions heavy hours despite good work life balance ratingGlassdoor
- New customerStryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical centerNew customer
- AcquisitionStryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offeringAcquisition
- Website changesStryker expanded its Mako robotics portfolio with the full market release of Mako RPS, a new handheld robotic knee replacement platform.Website changes
More 8-K signals at other companies
- SEC 8-K4D Molecular Therapeutics, Inc.4D Molecular Therapeutics initiates Phase 3 trial directly challenging competitor drug aflibercept.SEC 8-K
- SEC 8-KAdeia Inc.Adeia Inc. appoints new CEO Dipti Vachani, effective October 12, 2026, replacing outgoing CEO Paul E. Davis.SEC 8-K
- SEC 8-KAdicet Bio, Inc.Adicet Bio launching pivotal clinical trial in Q4 2026 after positive Phase 1 data for Prula-cel.SEC 8-K
The full record
From the Signal API recordDetails
- CIK
- 310764
- Accession number
- 0000310764-26-000041
- Timeframe
- Current quarter
- Filing year
- 2026
- Why it matters
- Vendor review likely
- Signal category
- Financial
Topics and mentions
Technologies
- Mako
- enabling technologies
Extraction
- Confidence
- High
- Relevance
- 85%
- Sentiment
- Neutral
- Detected
- Jun 30, 2026
- signal_type
sec-8k- signal_subtype
restructuringCharge
Use this data
Get every 8-K signal for Stryker and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Stryker this week?”
Send it to your own tools
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/61f01c39-90b0-41d4-a00a-7e216ac35531 returns this record as JSON. POST /v1/companies/enrich returns every signal for stryker.com.
{
"signal_id": "61f01c39-90b0-41d4-a00a-7e216ac35531",
"signal_type": "sec-8k",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-06-30T07:06:27.438+00:00",
"company": {
"name": "Stryker",
"domain": "stryker.com"
},
"data": {
"detail": "Stryker is combining its orthopaedic instruments portfolio with its Mako and enabling technologies portfolio into a single new business. This significant restructuring creates opportunities for vendors specializing in systems integration, business process re-engineering, and consolidated financial/operational reporting platforms.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Stryker creates new Ortho Tech business unit via major internal reorganization",
"excerpts": "In the first quarter 2026 Stryker Corporation (\"we\" or the \"Company\") announced a change in our organizational structure.",
"relevance": 0.85,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/310764/000031076426000041/syk-20260626.htm",
"filing_date": "2026-06-26",
"filing_year": 2026,
"fiscal_year_end": "06/26",
"sales_relevance": "Vendor review likely",
"signal_category": "financial",
"technologies_mentioned": [
"Mako",
"enabling technologies"
]
}
}
curl https://signals.autobound.ai/v1/signals/61f01c39-90b0-41d4-a00a-7e216ac35531 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"stryker.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.